Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+9.82%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$44.6B
AUM Growth
+$2.78B
(+6.7%)
Cap. Flow
+$292M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
21.42%
Holding
1,096
New
123
Increased
256
Reduced
361
Closed
182
Top Buys
| 1 |
Honeywell
HON
|
$255M |
| 2 |
Johnson Controls International
JCI
|
$222M |
| 3 |
Dover
DOV
|
$187M |
| 4 |
lululemon athletica
LULU
|
$184M |
| 5 |
Republic Services
RSG
|
$147M |
Top Sells
| 1 |
SIVB
SVB Financial Group
SIVB
|
$172M |
| 2 |
GE Aerospace
GE
|
$120M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$115M |
| 4 |
Fortive
FTV
|
$115M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$95.2M |
Sector Composition
| 1 | Technology | 23.96% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 9.86% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
251
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $42.7M | 0.1% |
469,618
-836,235
| -64% | -$76M |
|
252
Healthcare Realty
HR
$6.35B
| $41.6M | 0.09% |
2,150,000
+1,425,000
| +197% | +$27.5M |
|
253
Idexx Laboratories
IDXX
$51.4B
| $41.5M | 0.09% |
82,901
-1,300
| -2% | -$650K |
|
254
Ovintiv
OVV
$10.6B
| $41.3M | 0.09% |
1,144,949
-840,000
| -42% | -$30.3M |
|
255
Ecolab
ECL
$77.6B
| $41.1M | 0.09% |
248,125
-3,900
| -2% | -$646K |
|
256
Novo Nordisk
NVO
$245B
| $41M | 0.09% |
515,618
-192,754
| -27% | -$15.3M |
|
257
Agilent Technologies
A
$36.5B
| $41M | 0.09% |
296,294
-4,800
| -2% | -$664K |
|
258
Adient
ADNT
$2B
| $41M | 0.09% |
1,000,000
+500,000
| +100% | +$20.5M |
|
259
Estee Lauder
EL
$32.1B
| $40.4M | 0.09% |
163,984
-61,200
| -27% | -$15.1M |
|
260
Pool Corp
POOL
$12.4B
| $40.4M | 0.09% |
117,923
+4,400
| +4% | +$1.51M |
|
261
Middleby
MIDD
$7.32B
| $40.2M | 0.09% |
+274,000
| New | +$40.2M |
|
262
Autodesk
ADSK
$69.5B
| $39.8M | 0.09% |
191,089
+11,500
| +6% | +$2.39M |
|
263
Patria Investments
PAX
$2.21B
| $39.5M | 0.09% |
2,667,993
-129,135
| -5% | -$1.91M |
|
|
KDNY
264
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $39.4M | 0.09% |
1,704,000
+883,822
| +108% | +$20.5M |
|
265
Nucor
NUE
$33.8B
| $39.1M | 0.09% |
253,300
-7,600
| -3% | -$1.17M |
|
266
AES
AES
$9.21B
| $39M | 0.09% |
1,618,812
+939,400
| +138% | +$22.6M |
|
267
BioXcel Therapeutics
BTAI
$55.2M
| $38.8M | 0.09% |
130,124
+75,436
| +138% | +$22.5M |
|
268
Realty Income
O
$54.2B
| $38.8M | 0.09% |
613,000
-149,900
| -20% | -$9.49M |
|
269
Dow Inc
DOW
$17.4B
| $38.7M | 0.09% |
705,800
-10,000
| -1% | -$548K |
|
270
Pinnacle West Capital
PNW
$10.6B
| $38.7M | 0.09% |
488,283
-101,800
| -17% | -$8.07M |
|
271
GCM Grosvenor
GCMG
$680M
| $38.6M | 0.09% |
4,942,786
| – | – |
|
|
FLG
272
Flagstar Financial, Inc.
FLG
$5.39B
| $38.4M | 0.09% |
1,415,089
+189,912
| +16% | +$5.15M |
|
|
CBAY
273
DELISTED
Cymabay Therapeutics
CBAY
| $38.4M | 0.09% |
4,399,400
+3,899,400
| +780% | +$34M |
|
274
MetLife
MET
$52.9B
| $38.2M | 0.09% |
659,926
-1,510,400
| -70% | -$87.5M |
|
275
Dollar General
DG
$24.1B
| $37.7M | 0.08% |
178,900
-33,600
| -16% | -$7.07M |
|